{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:02:20Z","timestamp":1790913740591,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.cca.2006.11.024","type":"journal-article","created":{"date-parts":[[2006,12,21]],"date-time":"2006-12-21T15:14:16Z","timestamp":1166714056000},"page":"31-35","source":"Crossref","is-referenced-by-count":23,"title":["Relationship between serum levels of vascular endothelial growth factor, hepatocyte growth factor and matrix metalloproteinase-9 with biochemical markers of bone disease in multiple myeloma"],"prefix":"10.1016","volume":"379","author":[{"given":"Michael G.","family":"Alexandrakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Sfiridaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Miyakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermioni","family":"Kandidaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios","family":"Alegakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Margioris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2006.11.024_bib1","first-page":"394","article-title":"Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients","volume":"86","author":"Corso","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2006.11.024_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0009-8981(02)00246-2","article-title":"Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients","volume":"325","author":"Alexandrakis","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2006.11.024_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jnci\/94.1.17","article-title":"Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis","volume":"94","author":"Nemeth","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2006.11.024_bib4","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.febslet.2005.03.035","article-title":"Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis","volume":"579","author":"Ko","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cca.2006.11.024_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.leu.2403331","article-title":"Bone marrow endothelial cells increase the invasiveness of human multiple myeloma cells through upregulation of MMP-9: evidence for a role of hepatocyte growth factor","volume":"18","author":"Van de Broek","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.cca.2006.11.024_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1074-5521(96)90178-7","article-title":"Matrix metalloproteinases and the development of cancer","volume":"3","author":"Coussens","year":"1996","journal-title":"Chem Biol"},{"key":"10.1016\/j.cca.2006.11.024_bib7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","article-title":"Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells","volume":"90","author":"Barille","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cca.2006.11.024_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10428190009089428","article-title":"Matrix metalloproteinases in multiple myeloma","volume":"37","author":"Kelly","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cca.2006.11.024_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ijc.10642","article-title":"Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells","volume":"101","author":"Van Valckenborgh","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2006.11.024_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0024-3205(03)00434-X","article-title":"Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions","volume":"73","author":"Kumta","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.cca.2006.11.024_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion","volume":"13","author":"Westermarck","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2006.11.024_bib12","doi-asserted-by":"crossref","first-page":"25371","DOI":"10.1074\/jbc.274.36.25371","article-title":"A novel host\/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen","volume":"274","author":"Benbow","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.11.024_bib13","first-page":"673","article-title":"Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma","volume":"5","author":"Kurizaki","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cca.2006.11.024_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1054\/bjoc.2000.1445","article-title":"Hepatocyte growth factor\/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases","volume":"83","author":"Harvey","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2006.11.024_bib15","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1083\/jcb.151.4.879","article-title":"Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones","volume":"151","author":"Engsig","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cca.2006.11.024_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.1595","article-title":"Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells","volume":"97","author":"Monvoisin","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2006.11.024_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1600-0609.2000.90074.x","article-title":"Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma","volume":"64","author":"Abildgaard","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cca.2006.11.024_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hon.700","article-title":"Urinary N-telopeptide levels in multiple myeloma patients, correlation with Tc-99(m-sestaMIBI scintigraphy and other biochemical markers of disease activity","volume":"21","author":"Alexandrakis","year":"2003","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cca.2006.11.024_bib19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","article-title":"A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine","volume":"7","author":"Hanson","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2006.11.024_bib20","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0959-8049(98)00277-9","article-title":"Markers of bone resorption in patients treated with pamidronate","volume":"34","author":"Lipton","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cca.2006.11.024_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/clinchem\/36.7.1328","article-title":"Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen","volume":"36","author":"Melkko","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2006.11.024_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2006.11.024_bib23","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cca.2006.11.024_bib24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1515\/CCLM.2004.230","article-title":"Bone marrow microvascular density and angiogenic growth factors in multiple myeloma","volume":"42","author":"Alexandrakis","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2006.11.024_bib25","first-page":"800","article-title":"Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood","volume":"85","author":"Di Raimondo","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cca.2006.11.024_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07357909709018921","article-title":"Pathophysiology and management of bone disease in multiple myeloma","volume":"15","author":"Niesvizky","year":"1997","journal-title":"Cancer Invest"},{"key":"10.1016\/j.cca.2006.11.024_bib27","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2002.17.11.1921","article-title":"Role of the bone marrow microenvironment in multiple myeloma","volume":"17","author":"Roodman","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cca.2006.11.024_bib28","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0024-3205(00)01030-4","article-title":"Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma","volume":"68","author":"Ribatti","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.cca.2006.11.024_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF00316285","article-title":"Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover","volume":"54","author":"Rosen","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.cca.2006.11.024_bib30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1515\/CCLM.2005.160","article-title":"Systemic levels of interleukin-6 and matrix metalloproteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease","volume":"43","author":"Sfiridaki","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2006.11.024_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1096\/fj.01-0790com","article-title":"MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression","volume":"16","author":"Sounni","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2006.11.024_bib32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1096\/fasebj.7.15.8262328","article-title":"Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis","volume":"7","author":"Stetler-Stevenson","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2006.11.024_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/327239a0","article-title":"Scatter factor is a fibroblast-derived modulator of epithelial cell mobility","volume":"327","author":"Stoker","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.cca.2006.11.024_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.10304","article-title":"Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity","volume":"72","author":"Alexandrakis","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cca.2006.11.024_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cca.2006.11.024_bib36","doi-asserted-by":"crossref","first-page":"24655","DOI":"10.1074\/jbc.271.40.24655","article-title":"Concomitant expression of hepatocyte growth factor\/scatter factor and the receptor c-MET in human myeloma cell lines","volume":"271","author":"Borset","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2006.11.024_bib37","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V88.10.3998.bloodjournal88103998","article-title":"Hepatocyte growth factor and its receptor c-met in multiple myeloma","volume":"88","author":"Borset","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cca.2006.11.024_bib38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0955-2235(91)90014-U","article-title":"Structure and function of hepatocyte growth factor","volume":"3","author":"Nakamura","year":"1991","journal-title":"Prog Growth Factor Res"},{"key":"10.1016\/j.cca.2006.11.024_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2402875","article-title":"The hepatocyte growth factor\/Met pathway controls proliferation and apoptosis in multiple myeloma","volume":"17","author":"Derksen","year":"2003","journal-title":"Leukemia"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106007881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106007881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T14:14:52Z","timestamp":1587305692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898106007881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0009898106007881"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2006.11.024","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}